MedTrace Logo

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia

NCT01132456 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 312

Last updated 2016-06-13

No results posted yet for this study

Summary

The purpose of this study is to document the safety and overall clinical performance of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a patient population with long lesion(s) and/or dual vessels requiring stent implantation.

Conditions

Interventions

DEVICE

Drug eluting stent treatment

Endeavor RESOLUTE Zotarolimus-Eluting Coronary Stent Implantation

Sponsors & Collaborators

  • Medtronic Vascular

    lead INDUSTRY

Principal Investigators

  • Robaayah Zambahari, MBBS, MRCP, FRCP, FACC · National Heart Institute (IJN), Malaysia

  • Michael Kang-Yin Lee, MBBS · Queen Elizabeth Hospital, HK

  • Shirish Hiremath, MD · Ruby Hall Clinic, India

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2013-05-31
Completion
2016-04-30

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01132456 on ClinicalTrials.gov